CAS Medical Systems, Inc. (NASDAQ:CASM) will be releasing its Q3 2017 earnings data before the market opens on Monday, November 6th. Analysts expect CAS Medical Systems to post earnings of ($0.06) per share for the quarter.
CAS Medical Systems (NASDAQ:CASM) last issued its earnings results on Tuesday, August 8th. The medical technology company reported ($0.09) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.07) by ($0.02). The firm had revenue of $4.57 million during the quarter, compared to the consensus estimate of $5.41 million. On average, analysts expect CAS Medical Systems to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Shares of CAS Medical Systems, Inc. (CASM) opened at $0.79 on Friday. The company has a current ratio of 1.86, a quick ratio of 1.62 and a debt-to-equity ratio of -0.48. CAS Medical Systems, Inc. has a 12 month low of $0.74 and a 12 month high of $1.94.
Separately, ValuEngine cut shares of CAS Medical Systems from a “sell” rating to a “strong sell” rating in a research report on Friday, September 1st.
CAS Medical Systems Company Profile
CAS Medical Systems, Inc is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products for patient care. The Company designs, manufactures and distributes the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. It operates through Tissue Oximetry Monitoring, which includes sales of its FORE-SIGHT tissue oximeter monitors, sensors and accessories.
What are top analysts saying about CAS Medical Systems Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CAS Medical Systems Inc. and related companies.